Professor Mark Caulfield is the Chief Scientist at Genomics England. After graduating in Medicine in 1984, he trained in Clinical Pharmacology at St Bartholomew’s Hospital (Barts) where he developed a research programme in molecular genetics of hypertension and clinical research.

In 2000 Mark successfully bid for £3.1m to create the Barts and The London Genome Centre at the Queen Mary University of London and subsequently became Director of the William Harvey Research Institute.

Since 2008 he has directed the Barts National Institute of Health Research (NIHR) Cardiovascular Biomedical Research Unit/Centre. He is a Fellow of The Royal College of Physicians, has been elected to the Academy of Medical Sciences and became a Senior Investigator for the NIHR in 2013.